Parks Associates: 5% of US Internet Households Have Only a Pay-TV Service

Latest OTT research analyzes continued challenges for all players in the age of streaming DALLAS, Jan. 4, 2024 /PRNewswire/ — Parks Associates’ latest update of the firm’s Streaming Video Tracker reveals that just 5% of US internet households have only a pay-TV service, indicating legacy pay-TV companies continue to lose subscribers to streaming video services. However, the average… Continue reading Parks Associates: 5% of US Internet Households Have Only a Pay-TV Service

TikTok and Peloton Partner to Drive Accessibility of Fitness and Movement with First-of-Its Kind #TikTokFitness Peloton Hub

Brands Unite to Reimagine Fitness Offerings that will Inspire New Audiences to Move NEW YORK, Jan. 4, 2024 /PRNewswire/ — Peloton (NASDAQ: PTON), the leading connected fitness platform, and TikTok, the leading destination for short-form mobile video, today announced an exclusive partnership to bring Peloton’s world-class workout content to the TikTok community. Together the two… Continue reading TikTok and Peloton Partner to Drive Accessibility of Fitness and Movement with First-of-Its Kind #TikTokFitness Peloton Hub

Laars® Heating Systems announces acquisition of Electro Industries

Trusted U.S. manufacturer expands its residential, commercial and industrial space heating portfolio as customer needs evolve in response to new electrification policies and regulations ROCHESTER, N.H. , Jan. 4, 2024 /PRNewswire/ — Laars® Heating Systems, a subsidiary of Bradford White Corporation and a leading U.S. designer and manufacturer of boilers, water heaters, and pool heaters used in residential,… Continue reading Laars® Heating Systems announces acquisition of Electro Industries

SUCCESSFUL LAUNCH: NIKOLA PRODUCES 42, WHOLESALES 35 HYDROGEN FUEL CELL ELECTRIC TRUCKS FOR CUSTOMERS IN U.S. AND CANADA IN 2023

PHOENIX, Jan. 4, 2024 /PRNewswire/ — The elves weren’t the only ones busy during the 2023 holiday season; Nikola Corporation (Nasdaq: NKLA), a global leader in zero-emissions transportation and energy supply and infrastructure solutions, via the HYLA brand, in 2023 produced 42 and wholesaled 35 Class 8 Nikola hydrogen fuel cell electric vehicles (FCEVs). Continue Reading… Continue reading SUCCESSFUL LAUNCH: NIKOLA PRODUCES 42, WHOLESALES 35 HYDROGEN FUEL CELL ELECTRIC TRUCKS FOR CUSTOMERS IN U.S. AND CANADA IN 2023

Rigel Announces Collaboration with CONNECT to Conduct a Phase 2 Trial of Olutasidenib in Glioma

SOUTH SAN FRANCISCO, Calif., Jan. 4, 2024 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced a collaboration with CONNECT, an international collaborative network of pediatric cancer centers, to conduct a Phase 2 clinical trial to evaluate REZLIDHIA® (olutasidenib) in combination with temozolomide as maintenance therapy in newly diagnosed pediatric and young adult patients with high-grade glioma (HGG)… Continue reading Rigel Announces Collaboration with CONNECT to Conduct a Phase 2 Trial of Olutasidenib in Glioma

Bloomlife and PeriGen Partner to Improve Access to Critical Maternal and Fetal Health in the Face of Maternity Care Deserts

SAN FRANCISCO, Jan. 4, 2024 /PRNewswire/ — Bloomlife, an award-winning maternal health company, and PeriGen, the market leader in applying artificial intelligence to improve safety in childbirth, today announced a partnership to improve access to essential monitoring of high-risk pregnancies. The partnership will combine remote patient monitoring and AI-driven analytics to cost-effectively bring these procedures… Continue reading Bloomlife and PeriGen Partner to Improve Access to Critical Maternal and Fetal Health in the Face of Maternity Care Deserts

Jiangsu Vcare Files NDA for Vicagrel Capsules with US FDA

NANJING, China, Jan. 4, 2024 /PRNewswire/ — On December 28, 2023, Jiangsu Vcare PharmaTech Co., Ltd. (Jiangsu Vcare) successfully submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Vicagrel capsule, which is indicated to treat a range of thrombotic cardiovascular and cerebrovascular diseases, including acute coronary syndrome, ischaemic stroke, and… Continue reading Jiangsu Vcare Files NDA for Vicagrel Capsules with US FDA

TMG Entertainment Network and K.Jam Launch Digital Broadcast Media Company in Nevada

LAS VEGAS, Jan. 4, 2024 /PRNewswire/ — Entertainment industry veteran Paolo Sadri of TMG Entertainment Network and Hollywood producer Kia Jam of K.Jam Media have joined forces to form TJM Network, an independent sports and entertainment broadcast media company based in Las Vegas, with offices in Beverly Hills. The TJM Network will create and produce in-depth,… Continue reading TMG Entertainment Network and K.Jam Launch Digital Broadcast Media Company in Nevada

Avenzo Therapeutics Announces Global License of AVZO-021 (ARTS-021), a Potentially Best-in-Class Clinical Stage CDK2 Inhibitor from Allorion Therapeutics

– AVZO-021 demonstrated a potential best-in-class preclinical potency, selectivity and pharmacokinetic profile – AVZO-021 is currently in an ongoing U.S.-based Phase 1 clinical study in advanced solid tumors – Avenzo also obtains an exclusive option to an additional preclinical program planned for Investigational New Drug (IND) submission in early 2025 SAN DIEGO, Calif. and NATICK, Mass.,… Continue reading Avenzo Therapeutics Announces Global License of AVZO-021 (ARTS-021), a Potentially Best-in-Class Clinical Stage CDK2 Inhibitor from Allorion Therapeutics

Seeing Machines to showcase cutting edge interior sensing technology at CES 2024

CANBERRA, Australia, Jan. 3, 2024 /PRNewswire/ — Seeing Machines Limited (AIM: SEE), the advanced computer vision technology company that designs AI-powered operator monitoring systems to improve transport safety, will showcase its world-leading interior sensing technology at the Consumer Electronics Show (CES) 2024 in Las Vegas. Continue Reading Glimpse what Seeing Machines will be showing at… Continue reading Seeing Machines to showcase cutting edge interior sensing technology at CES 2024